The Board of Directors at Vijaya Diagnostic Centre has approved the amalgamation of Medinova Diagnostic Services Limited. Effective November 04, 2025, Medinova will be dissolved, with its assets and liabilities transferred to Vijaya. Shareholders of Medinova will receive one Vijaya share for every 22 Medinova shares. The move aims to streamline operations and enhance the company’s market position. This includes the cancellation of shares held by Vijaya Diagnostic in Medinova.
Amalgamation Approval
Vijaya Diagnostic Centre announced that its Board of Directors has approved the proposed amalgamation of Medinova Diagnostic Services Limited, effective November 04, 2025. This decision follows an order passed on October 13, 2025, by the National Company Law Tribunal (NCLT), Hyderabad, sanctioning the scheme.
Key Dates and Ratios
The effective date of the scheme is Tuesday, November 04, 2025. As per the approved scheme, for every 22 equity shares of Medinova, shareholders will receive 1 equity share of Vijaya Diagnostic Centre.
The record date for determining shareholders eligible for the share exchange is November 25, 2025.
Impact on Medinova
Effective November 04, 2025, Medinova Diagnostic Services Limited will be dissolved. All offices of Directors, Key Managerial Personnel, and Statutory Auditors of Medinova will be vacated.
Subsidiary Update
Following the amalgamation, “Medinova Millennium MRI Services LLP” will become a Wholly Owned Subsidiary of Vijaya Diagnostic Centre, effective November 04, 2025.
Cancellation of Investment
As part of the scheme, the investment of 62,02,220 equity shares in Medinova Diagnostic Services Limited will be cancelled.
Authorized Share Capital
Post-amalgamation, the authorized share capital of Vijaya Diagnostic Centre will increase to INR 230,500,000, divided into 230,500,000 equity shares with a face value of INR 1 each.
Source: BSE